Charles Ryhee
Stock Analyst at TD Cowen
(2.47)
# 2,157
Out of 4,828 analysts
25
Total ratings
52.38%
Success rate
0.31%
Average return
Main Sectors:
Stocks Rated by Charles Ryhee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVS CVS Health | Maintains: Buy | $73 → $80 | $66.97 | +19.46% | 5 | Nov 25, 2024 | |
| WBA Walgreens Boots Alliance | Maintains: Buy | $16 → $14 | $11.22 | +24.78% | 6 | Oct 22, 2024 | |
| MCK McKesson | Maintains: Buy | $563 → $652 | $693.46 | -5.98% | 4 | May 8, 2024 | |
| CVX Chevron | Maintains: Outperform | $185 → $170 | $138.49 | +22.75% | 3 | Feb 24, 2023 | |
| EVH Evolent Health | Maintains: Outperform | $57 → $59 | $9.05 | +551.93% | 2 | Jan 30, 2023 | |
| CAH Cardinal Health | Maintains: Market Perform | $59 → $72 | $148.22 | -51.42% | 1 | Aug 16, 2022 | |
| OTRK Ontrak | Downgrades: Underperform | $3,150 → $810 | $1.64 | +49,290.24% | 2 | Aug 20, 2021 | |
| TDOC Teladoc Health | Maintains: Outperform | $240 → $188 | $7.11 | +2,544.16% | 1 | Aug 9, 2021 | |
| OSCR Oscar Health | Initiates: Market Perform | $29 | $17.11 | +69.49% | 1 | Mar 29, 2021 |
CVS Health
Nov 25, 2024
Maintains: Buy
Price Target: $73 → $80
Current: $66.97
Upside: +19.46%
Walgreens Boots Alliance
Oct 22, 2024
Maintains: Buy
Price Target: $16 → $14
Current: $11.22
Upside: +24.78%
McKesson
May 8, 2024
Maintains: Buy
Price Target: $563 → $652
Current: $693.46
Upside: -5.98%
Chevron
Feb 24, 2023
Maintains: Outperform
Price Target: $185 → $170
Current: $138.49
Upside: +22.75%
Evolent Health
Jan 30, 2023
Maintains: Outperform
Price Target: $57 → $59
Current: $9.05
Upside: +551.93%
Cardinal Health
Aug 16, 2022
Maintains: Market Perform
Price Target: $59 → $72
Current: $148.22
Upside: -51.42%
Ontrak
Aug 20, 2021
Downgrades: Underperform
Price Target: $3,150 → $810
Current: $1.64
Upside: +49,290.24%
Teladoc Health
Aug 9, 2021
Maintains: Outperform
Price Target: $240 → $188
Current: $7.11
Upside: +2,544.16%
Oscar Health
Mar 29, 2021
Initiates: Market Perform
Price Target: $29
Current: $17.11
Upside: +69.49%